Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Allografting

HLA-matched sibling transplantation with BM and CD34+-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD

Bone Marrow Transplantation volume 45, pages 1497–1501 (2010)Cite this article

Subjects

Abstract

The transplantation of a large number of stem cells can overcome graft rejection but with the increased risk of GVHD. In this study, we analyzed the outcome of 32 adult patients with acquired severe aplastic anemia (SAA) who were at a high risk for graft rejection, including multiple transfusions (median 147 units, range 20–680) and long disease duration (median 67 months, range 3–347), and who had received both BM and CD34+-purified PBSCs from an HLA-matched sibling donor to reduce graft rejection. T cells in PBSCs were depleted using a magnetic-activated cell sorting method (CliniMACS system). Conditioning regimens consisted largely of CY and antithymocyte globulin (ATG) with fludarabine (FLU) or procarbazine (PCB). With a median follow-up of 89 months, the 8-year probability of survival was 87.5%. Neutrophils and plts promptly recovered, and none of the patients developed graft failure. The cumulative incidences of acute and chronic GVHD were 9.4 and 18.0%, respectively. Sustained engraftment and excellent survival without an apparent increase in the rate of GVHD in high-risk patients using the current approach showed that high-dose SCT with both BM and CD34+-purified PBSCs may yield better outcomes in heavily transfused and/or allo-immunized patients with SAA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Kim HJ, Park CY, Park YH, Kim JH, Kim DW, Min WS et al. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients. Bone Marrow Transplant 2003; 31: 79–86.

    Article  CAS  PubMed  Google Scholar 

  2. Ades L, Mary JY, Robin M, Ferry C, Porcher R, Esperou H et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood 2004; 103: 2490–2497.

    Article  CAS  PubMed  Google Scholar 

  3. Horowitz MM . Current status of allogeneic bone marrow transplantation in acquired aplastic anemia. Semin Hematol 2000; 37: 30–42.

    Article  CAS  PubMed  Google Scholar 

  4. Champlin RE, Perez WS, Passweg JR, Klein JP, Camitta BM, Gluckman E et al. Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. Blood 2007; 109: 4582–4585.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Deeg HJ, Leisenring W, Storb R, Nims J, Flowers ME, Witherspoon RP et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 1998; 91: 3637–3645.

    CAS  PubMed  Google Scholar 

  6. Young NS, Calado RT, Scheinberg P . Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006; 108: 2509–2519.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Stroncek DF, Rebulla P . Platelet transfusions. Lancet 2007; 370: 427–438.

    Article  PubMed  Google Scholar 

  8. Klein HG, Spahn DR, Carson JL . Red blood cell transfusion in clinical practice. Lancet 2007; 370: 415–426.

    Article  PubMed  Google Scholar 

  9. Storb R, Prentice RL, Thomas ED, Appelbaum FR, Deeg HJ, Doney K et al. Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia. Br J Haematol 1983; 55: 573–585.

    Article  CAS  PubMed  Google Scholar 

  10. Deeg HJ, Self S, Storb R, Doney K, Appelbaum FR, Witherspoon RP et al. Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors. Blood 1986; 68: 1363–1368.

    CAS  PubMed  Google Scholar 

  11. Champlin RE, Horowitz MM, van Bekkum DW, Camitta BM, Elfenbein GE, Gale RP et al. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood 1989; 73: 606–613.

    CAS  PubMed  Google Scholar 

  12. Schrezenmeier H, Passweg JR, Marsh JC, Bacigalupo A, Bredeson CN, Bullorsky E et al. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia: a report from the European group for blood and marrow transplantation and the center for international blood and marrow transplant research. Blood 2007; 110: 1397–1400.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Srinivasan R, Takahashi Y, McCoy JP, Espinoza-Delgado I, Dorrance C, Igarashi T et al. Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation. Br J Haematol 2006; 133: 305–314.

    Article  CAS  PubMed  Google Scholar 

  14. Min CK, Kim DW, Lee JW, Han CW, Min WS, Kim CC . Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose. Haematologica 2001; 86: 303–310.

    CAS  PubMed  Google Scholar 

  15. Atkinson K, Fay K, Nivison-Smith I, Downs K . Lenograstim administration to HLA-identical donor-recipient pairs to accelerate marrow recovery post-transplant. Bone Marrow Transplant 1997; 19: 15–21.

    Article  CAS  PubMed  Google Scholar 

  16. Burt RK, Kuzel TM, Fishman M, Brush M, Villa M, Welles C et al. Stem cell component therapy: supplementation of unmanipulated marrow with CD34 enriched peripheral blood stem cells. Bone Marrow Transplant 1999; 23: 381–386.

    Article  CAS  PubMed  Google Scholar 

  17. Min CK, Kim DW, Lee JW, Han CW, Min WS, Kim CC . Supplemental peripheral blood stem cells to decrease marrow rejection in adult patients with severe aplastic anemia. Am J Hematol 2002; 69: 15–22.

    Article  PubMed  Google Scholar 

  18. Camitta BM, Thomas ED, Nathan DG, Santos DG, Gordon-Smith EC, Gale RP et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 1976; 48: 63–70.

    CAS  PubMed  Google Scholar 

  19. Lee S, Kim YJ, Min CK, Kim HJ, Eom KS, Kim DW et al. The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 2005; 105: 3449–3457.

    Article  CAS  PubMed  Google Scholar 

  20. Min CK, Kim SY, Lee MJ, Eom KS, Kim YJ, Kim HJ et al. Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation. Bone Marrow Transplant 2006; 38: 149–156.

    Article  CAS  PubMed  Google Scholar 

  21. Handgretinger R, Lang P, Schumm M, Taylor G, Neu S, Koscielnak E et al. Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting. Bone Marrow Transplant 1998; 21: 987–993.

    Article  CAS  PubMed  Google Scholar 

  22. Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562–1568.

    Article  CAS  PubMed  Google Scholar 

  23. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  24. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.

    Article  CAS  PubMed  Google Scholar 

  25. Gray R . A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141–1154.

    Article  Google Scholar 

  26. Herrera-Garza J, Jaime-Perez J, Montemayor J, Ibarra-Peart R, Gomez-Almaguer D . High-dose peripheral blood stem cell transplant for multitransfused severe aplastic anaemia patients without antithymocyte globulin in the conditioning regimen. Bone Marrow Transplant 1999; 24: 845–848.

    Article  CAS  PubMed  Google Scholar 

  27. Schwinger W, Urban C, Lackner H, Kerbl R, Benesch M, Dornbusch HJ et al. Unrelated peripheral blood stem cell transplantation with ‘megadoses’ of purified CD34+ cells in three children with refractory severe aplastic anemia. Bone Marrow Transplant 2000; 25: 513–517.

    Article  CAS  PubMed  Google Scholar 

  28. Storek J, Gooley T, Siadak M, Bensinger WI, Maloney DG, Chauncey TR et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 1997; 90: 4705–4709.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, Department of Internal Medicine, Catholic Blood and Marrow Transplantation Center, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

    B S Cho, Y J Kim, H J Kim, S Lee, C K Min, S G Cho, W S Min, C W Park, C C Kim & J W Lee

  2. Division of Hematology, Department of Internal Medicine, St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

    K S Eom

Authors
  1. B S Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K S Eom
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y J Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H J Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C K Min
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S G Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. W S Min
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C W Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C C Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. J W Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J W Lee.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cho, B., Eom, K., Kim, Y. et al. HLA-matched sibling transplantation with BM and CD34+-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD. Bone Marrow Transplant 45, 1497–1501 (2010). https://doi.org/10.1038/bmt.2009.374

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2009.374

Keywords

This article is cited by

Search

Advanced search

Quick links